Among of them, CCNA2, CENPA, BRCA2, RFC3, PSME3, ENSA and TERF2 were significantly decreased (log2FC<-1) in CTD treated HCC cells (Fig. 4D). This evidence concerns the gene BRCA2 and hepatocellular carcinoma.